Meanwhile, ginsenoside Rg2 improved ICH-induced neurological disease and blood-brain barrier dysfunction in animal models of pre-eclampsia by modulating the toll-like Receptor 4 (TLR4)/nuclear factor kappa-B (NF-κB) signaling pathway, the above contents are shown in Figure 2. This evidence concerns the gene TLR4 and nervous system disorder.